Analystreport

Albireo Pharma, Inc. (NASDAQ: ALBO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations